Spotlight On... SAP makes pitch for precision medicine market with a pair of products; Roche wraps up Kapa buyout; Novo Nordisk inks deal with IBM Watson; and more...

SAP has introduced a pair of products designed to advance precision medicine by helping biopharma companies and healthcare organizations extract insights from data. Both the products, SAP Foundation for Health and SAP Medical Research Insights, are based on SAP HANA, the company's relational database management system. "You get an unprecedented ability to handle inputs like medical research, electronic health records and human genome sequencing," SAP CEO Bill McDermott said in a statement. Release

> Roche ($RHHBY) wrapped up the acquisition of genomic tool provider Kapa Biosystems. Release

> Novo Nordisk ($NVO) hooked up with IBM ($IBM) to apply Watson to diabetes care. More

> AstraZeneca ($AZN) teamed up with Voluntis to develop a companion mobile app for women with ovarian cancer. Article

> Google Life Sciences rebranded as Verily, an antiquated English word meaning truly or certainly. Item

> Illumina ($ILMN) picked four startups to take part in the third cycle of its business accelerator program. News

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.